Optimal Structure Requirements for Pluronic Block Copolymers in Modifying P-glycoprotein Drug Efflux Transporter Activity in Bovine Brain Microvessel Endothelial Cells

Pluronic block copolymer P85 was shown to inhibit the P-glycoprotein (Pgp) drug efflux system and to increase the permeability of a broad spectrum of drugs in the blood-brain barrier (BBB). However, there is an entire series of Pluronics varying in lengths of propylene oxide and ethylene oxide and overall lipophilicity. This study identifies those structural characteristics of Pluronics required for maximal impact on drug efflux transporter activity in bovine brain microvessel endothelial cells (BBMECs). Using a wide range of block copolymers, differing in hydrophilic-lipophilic balance (HLB), this study shows that lipophilic Pluronics with intermediate length of propylene oxide block (from 30 to 60 units) and HLB <20 are the most effective at inhibiting Pgp efflux in BBMECs. The methods used included 1) cellular accumulation studies with the Pgp substrate rhodamine 123 in BBMECs to assess Pgp activity; 2) luciferin/luciferase ATP assay to evaluate changes in cellular ATP; 3) 1,6-diphenyl-1,3,5-hexatriene membrane microviscosity studies to determine alterations in membrane fluidity; and 4) Pgp ATPase assays using human Pgp-expressing membranes. Pluronics with intermediate lipophilic properties showed the strongest fluidization effect on the cell membranes along with the most efficient reduction of intracellular ATP synthesis in BBMEC monolayers. The relationship between the structure of Pluronic block copolymers and their biological response-modifying effects in BBMECs are useful for determining formulations with maximal efficacy for increasing BBB permeability.

[1]  Donald W. Miller,et al.  Application of cultured endothelial cells of the brain microvasculature in the study of the blood-brain barrier , 1992 .

[2]  M. Grever,et al.  Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen. , 1994, Molecular pharmacology.

[3]  V. Alakhov,et al.  Block copolymeric biotransport carriers as versatile vehicles for drug delivery. , 1998, Expert opinion on biological therapy.

[4]  Alexander V. Kabanov,et al.  Pluronic P85 Increases Permeability of a Broad Spectrum of Drugs in Polarized BBMEC and Caco-2 Cell Monolayers , 1999, Pharmaceutical Research.

[5]  S. Pizzo,et al.  A new procedure for the synthesis of polyethylene glycol-protein adducts; effects on function, receptor recognition, and clearance of superoxide dismutase, lactoferrin, and alpha 2-macroglobulin. , 1983, Analytical biochemistry.

[6]  J. Ruysschaert,et al.  Intracellular distribution of lipophilic fluorescent probes in mammalian cells. , 1977, Biochimica et biophysica acta.

[7]  T. A. Hatton,et al.  Micellization of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) triblock copolymers in aqueous solutions: Thermodynamics of copolymer association , 1994 .

[8]  Teruo Okano,et al.  Soluble Self-Assembled Block Copolymers for Drug Delivery , 1999, Pharmaceutical Research.

[9]  B. Chazotte.  Comparisons of the relative effects of polyhydroxyl compounds on local versus long-range motions in the mitochondrial inner membrane. Fluorescence recovery after photobleaching, fluorescence lifetime, and fluorescence anisotropy studies. , 1994, Biochimica et biophysica acta.

[10]  Alexander V. Kabanov,et al.  Effects of Pluronic P85 Unimers and Micelles on Drug Permeability in Polarized BBMEC and Caco-2 Cells , 1998, Pharmaceutical Research.

[11]  R. Proulx,et al.  A combination of poloxamers increases gene expression of plasmid DNA in skeletal muscle , 2000, Gene Therapy.

[12]  V. Alakhov,et al.  Hypersensitizing effect of pluronic L61 on cytotoxic activity, transport, and subcellular distribution of doxorubicin in multiple drug-resistant cells. , 1996, Cancer research.

[13]  A. Isetta,et al.  MTT colorimetric assay for testing macrophage cytotoxic activity in vitro. , 1990, Journal of immunological methods.

[14]  N. Melik-Nubarov,et al.  The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles , 1989, FEBS letters.

[15]  D. Miller,et al.  The expression of multidrug resistance-associated protein (MRP) in pancreatic adenocarcinoma cell lines. , 1996, Cancer letters.

[16]  Donald W. Miller,et al.  Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies. , 2001, The Journal of pharmacology and experimental therapeutics.

[17]  A. Kabanov,et al.  Interactions of pluronic block copolymers with brain microvessel endothelial cells: evidence of two potential pathways for drug absorption. , 1997, Bioconjugate chemistry.

[18]  Pierre Lemieux,et al.  Block copolymeric biotransport carriers as versatile vehicles for drug delivery , 2001, Expert opinion on investigational drugs.

[19]  M. Yokoyama.  Block copolymers as drug carriers. , 1992, Critical reviews in therapeutic drug carrier systems.

[20]  R B Schifman,et al.  ATP assay: ability to distinguish cytostatic from cytocidal anticancer drug effects. , 1986, Journal of the National Cancer Institute.

[21]  S. D. de Laat,et al.  Microviscosity modulation during the cell cycle of neuroblastoma cells. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[22]  N. Melik-Nubarov,et al.  Effect of ethylene oxide and propylene oxide block copolymers on the permeability of bilayer lipid membranes to small solutes including doxorubicin. , 2000, Biochimica et biophysica acta.

[23]  M. Shinitzky,et al.  Microviscosity parameters and protein mobility in biological membranes. , 1976, Biochimica et biophysica acta.

[24]  P. J. Callahan,et al.  1-[4-(Trimethylamino)phenyl]-6-phenylhexa-1,3,5-triene: synthesis, fluorescence properties, and use as a fluorescence probe of lipid bilayers. , 1981, Biochemistry.

[25]  W. T. Beck,et al.  Effect of modulators on the ATPase activity and vanadate nucleotide trapping of human P-glycoprotein. , 1998, Biochemical pharmacology.

[26]  K. Loechner,et al.  Estradiol induction of rhodamine 123 efflux and the multidrug resistance pump in rat pituitary tumor cells. , 1993, Molecular pharmacology.

[27]  D. Miller,et al.  Use of rhodamine 123 to examine the functional activity of P-glycoprotein in primary cultured brain microvessel endothelial cell monolayers. , 1996, Life sciences.

[28]  Y. Assaraf,et al.  Membrane fluidization by ether, other anesthetics, and certain agents abolishes P-glycoprotein ATPase activity and modulates efflux from multidrug-resistant cells. , 1999, European journal of biochemistry.

[29]  I. Pastan,et al.  Biochemical, cellular, and pharmacological aspects of the multidrug transporter. , 1999, Annual review of pharmacology and toxicology.

[30]  R. Schinzel,et al.  Photometric microtiter assay of inorganic phosphate in the presence of acid-labile organic phosphates. , 1995, Analytical biochemistry.

[31]  A. Kabanov,et al.  Mechanism of pluronic effect on P-glycoprotein efflux system in blood-brain barrier: contributions of energy depletion and membrane fluidization. , 2001, The Journal of pharmacology and experimental therapeutics.